| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1492889A2 Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases |
| 01/05/2005 | EP1492885A2 Schizophrenia associated genes |
| 01/05/2005 | EP1492883A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 01/05/2005 | EP1492868A2 Method of modulating inflammatory response |
| 01/05/2005 | EP1492803A1 New analogs of nitrobenzylthioinosine |
| 01/05/2005 | EP1492796A1 Substituted amino isoxazoline derivatives and their use as anti-depressants. |
| 01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/05/2005 | EP1492794A1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 01/05/2005 | EP1492793A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/05/2005 | EP1492792A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 01/05/2005 | EP1492790A1 Imidazo fused compounds |
| 01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
| 01/05/2005 | EP1492786A1 Pyridinoylpiperidines as 5-ht1f agonists |
| 01/05/2005 | EP1492785A1 New compounds |
| 01/05/2005 | EP1492784A2 Substituted 2,3-diphenyl pyridines |
| 01/05/2005 | EP1492782A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 01/05/2005 | EP1492781A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492778A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
| 01/05/2005 | EP1492595A1 Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
| 01/05/2005 | EP1492552A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 01/05/2005 | EP1492546A1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 01/05/2005 | EP1492544A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
| 01/05/2005 | EP1492542A1 Hormone replacement therapy |
| 01/05/2005 | EP1492541A1 Pharmaceutical compositions comprising a 11-beta hydroxysteroid dehydrogenase inhibitor and a diuretic agent |
| 01/05/2005 | EP1492540A1 The use of devazepide as analgesic agent |
| 01/05/2005 | EP1492539A1 Statin therapy for enhancing cognitive maintenance |
| 01/05/2005 | EP1492533A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis |
| 01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
| 01/05/2005 | EP1492525A2 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 01/05/2005 | EP1492516A2 Use of mob-5 in pain |
| 01/05/2005 | EP1492512A1 Method for systemic drug delivery through the nail |
| 01/05/2005 | EP1492508A1 Controlled release dosage forms |
| 01/05/2005 | EP1492506A2 Matrix for sustained, invariant and independent release of active compounds |
| 01/05/2005 | EP1492505A2 Pharmaceutical preparation containing oxycodone and naloxone |
| 01/05/2005 | EP1397138B1 ACTIVE INGREDIENT COMBINATION (e.g. galanthamine or desoxypeganine with acamprosate or Memantine) FOR TREATING A DEPENDENCE ON ADDICTIVE SUBSTANCES OR NARCOTICS |
| 01/05/2005 | EP1282414B1 Felbamate derived compounds for treating neuropathic pain |
| 01/05/2005 | EP1274687B1 1,2,3,4- tetrahydroisoquinoline derivatives |
| 01/05/2005 | EP1244440B1 Agonists specific for the peripheral cannabinoid receptor |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | EP1133300B1 Desmethylolanzapine compositions and methods |
| 01/05/2005 | EP1006110B8 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 01/05/2005 | EP0996619B1 Tropane analogs and methods for inhibition of monoamine transport |
| 01/05/2005 | EP0957914B1 Formulation of 5-ht agonists |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | DE10327428A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
| 01/05/2005 | DE10326940A1 Indol-Derivate Indole derivatives |
| 01/05/2005 | DE10326939A1 Indol-Derivate Indole derivatives |
| 01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
| 01/05/2005 | CN1561338A Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 01/05/2005 | CN1561336A Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 01/05/2005 | CN1561334A Indole derivatives as COXII inhibitors |
| 01/05/2005 | CN1561226A Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 01/05/2005 | CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1561214A New formulations and use thereof |
| 01/05/2005 | CN1561213A New formulations and use thereof |
| 01/05/2005 | CN1561212A Benzimidazolidinone derivatives as muscarinic agents |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/05/2005 | CN1561206A Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| 01/05/2005 | CN1561203A Pharmaceutical salts |
| 01/05/2005 | CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 01/05/2005 | CN1561200A Flashmelt oral dosage formulation |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1559609A Spirit relieving drink and its preparation method |
| 01/05/2005 | CN1559591A Medicine for treating hemicrania |
| 01/05/2005 | CN1559585A High efficioncy stop smoking buccal tablets |
| 01/05/2005 | CN1559486A Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia |
| 01/05/2005 | CN1559442A Soft capsule of dried oviduct fat of forest frog |
| 01/05/2005 | CN1559418A Pripping pills of gastrodin, and prepn. method therefor |
| 01/05/2005 | CN1559417A Gastrodin venous injection liquid, and its prepn. method |
| 01/05/2005 | CN1559416A Dripping pills of acetyl-gastrodin, and prepn. method therefor |
| 01/05/2005 | CN1559407A Self-micro emulsion solft capsule of dihydropyridine type calcium ion agonist, and its prepn. method |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1559388A Tramadol hydrochloride oral disintegration tablets, and prepn. method therefor |
| 01/05/2005 | CN1183149C Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 01/05/2005 | CN1183148C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183126C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 01/05/2005 | CN1183116C Substituted isoquinoline derivatives and pharmaceutical composition containing them, its preparation method and use |
| 01/05/2005 | CN1183101C Derivatives of alpha-amino acid phenyl ester |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/05/2005 | CN1182864C Medicine for treating vascular denmentia disease and preparation method |
| 01/05/2005 | CN1182847C Combination of selective 5-HTIA antagonist and selective h5-HTIB antagonist or partial agonist |